IP Library Granted Patent US 7,390,797
Granted Patent B2
US 7,390,797 · App. 10/503,216 · Granted Jun 24, 2008

Fused indazole compounds

Assignee: Eisai Co., Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,390,797
App. No.
10/503,216
Granted
Jun 24, 2008
Kind
B2
Abstract

The present invention provides a novel fused indazole compound having an excellent JNK inhibitory action. More specifically, it provides a compound represented by the following formula, a salt thereof or a hydrate of them. Wherein Z 11 and Z 12 each independently represent a carbonyl group, a methylene group, etc.; represents a double bond or a single bond; R 1a represents a hydrogen atom, etc.; the ring A represents a benzene ring, a naphthalene ring or a 5- to 10-membered aromatic heterocyclic ring, etc.; and R 2a , R 2b and R 2c each independently represent (1) a hydrogen atom, (2) a halogen atom, (3) a nitro group, etc.

Claims (23)

1. A compound represented by the following formula, a salt thereof or a hydrate of them

wherein Z 11 and Z 12 each independently represent a carbonyl group, an oxygen atom, a sulfur atom, or a methine group which may be substituted, a methylene group which may be substituted or a nitrogen atom which may be substituted; represents a double bond or a single bond; R 1a represents a hydrogen atom, a C 1 -C 6 alkyl group, a phenyl group or a benzyl group; R 2a , R 2b and R 2c each independently represent a group selected from Substituent Group (a); the ring A represents a benzene ring which may have one to three groups selected from Substituent Group (a), a naphthalene ring which may have one to three groups selected from Substituent Group (a) or a 5- to 10-membered aromatic heterocyclic ring which may have one to three groups selected from Substituent Group (a);

Substituent Group (a)

(1) a hydrogen atom, (2) halogen atoms, (3) a nitro group, (4) a hydroxyl group, (5) a cyano group, (6) a carboxyl group, (7) an amino group, (8) a formyl group or (9) a group represented by the formula:

wherein X 1 and X 2 each independently represent a single bond, —CO—, —SO 2 — or C 1 -C 6 -methylene group; X 3 represents a single bond, —CO—, —SO 2 , —O—, —CO—O— or —O—CO—; R 3b represents a C 1 -C 6 alkylene group or a single bond; R 3a and R 3c represent a hydrogen atom, a C 1 -C 6 alkyl group which may be substituted, a C 2 -C 6 alkenyl group which may be substituted, a C 2 -C 6 alkynyl group which may be substituted, a C 3 -C 8 cycloalkyl group which may be substituted, a C 6 -C 14 aromatic cyclic hydrocarbon group which may be substituted, a 5- to 14-membered aromatic heterocyclic group which may be substituted or a hydrogen atom, provided that 6,7-dihydrobenzo[1,2]cyclohepta[3,4,5-cd]indazole is excluded.

2. A compound represented by the following formula, a salt thereof or a hydrate of them:

wherein Z 2 represents a 1,2-ethylene group which may be substituted, a 1,2-vinylene group which may be substituted, an oxymethylene group which may be substituted, an aminomethylene group which may be substituted, an amide group which may be substituted or an ester group; and the ring A, R 1a , R 2a , R 2b and R 2c have the same meanings as the ring A, R 1a , R 2a , R 2b and R 2c described in claim 1 , provided that 6,7-dihydrobenzo[1,2]cyclohepta[3,4,5-cd]indazole is excluded.

3. A compound represented by the following formula, a salt thereof or a hydrate of them

wherein R 1a , R 2a , R 2b and R 2c have the same meanings as R 1a , R 2a , R 2b and R 2c described in claim 1 , respectively; Z 2 represents a 1,2-ethylene group which may be substituted, a 1,2-vinylene group which may be substituted, an oxymethylene group which may be substituted, an aminomethylene group which may be substituted, an amide group which may be substituted, or an ester group; and R 2d , R 2e , R 2f , R 2g , R 2h and R 2i each independently represent a substituent selected from the Substituent Group (a) described in claim 1 .

4. A compound represented by the following formula, a salt thereof or a hydrate of them:

wherein R 1a , R 2a , R 2b and R 2c have the same meanings as R 1a , R 2a , R 2b and R 2c described in claim 1 , respectively; Z 2 represents a 1,2-ethylene group which may be substituted, a 1,2-vinylene group which may be substituted, an oxymethylene group which may be substituted, an aminomethylene group which may be substituted, an amide group which may be substituted, or an ester group; R 2d , R 2e , R 2f and R 2g each independently represent a substituent selected from the Substituent Group (a) described in claim 1 ; and Z 3 represents a nitrogen atom, an oxygen atom, a sulfur atom or a group represented by the formula —NR 4b — wherein R 4b represents a hydrogen atom or a C 1 -C 6 alkyl group.

5. A compound represented by the following formula, a salt thereof or a hydrate of them:

wherein R 1a , R 2a , R 2b and R 2c have the same meanings as R 1a , R 2a , R 2b and R 2c described in claim 1 , respectively; Z 2 represents a 1,2-ethylene group which may be substituted, a 1,2-vinylene group which may be substituted, an oxymethylene group which may be substituted, an aminomethylene group which may be substituted, an amide group which may be substituted, or an ester group; R 2d , R 2e , R 2f and R 2g each independently represent a substituent selected from the Substituent Group (a) described in claim 1 ; and Z 3 represents a nitrogen atom, an oxygen atom, a sulfur atom or a group represented by the formula —NR 4b — wherein R 4b repesents a hydrogen atom or a C 1 -C 6 group.

6. A compound represented by the following formula, a salt thereof or a hydrate of them:

wherein R 1a , R 2a , R 2b and R 2c have the same meanings as R 1a , R 2a , R 2b and R 2c described in claim 1 , respectively; Z 2 represents a 1,2-ethylene group which may be substituted, a 1,2-vinylene group which may be substituted, an oxymethylene group which may be substituted, an aminomethylene group which may be substituted, an amide group which may be substituted, or an ester group; and R 2d , R 2e , R 2f and R 2g each independently represent a substituent selected from the Substituent Group (a) described in claim 1 , provided that 6,7-dihydrobenzo[1,2]cyclohepta[3,4,5-cd]indazole is excluded.

7. The compound according to any one of claims 3 to 6 , a salt thereof or a hydrate of them, wherein at least five of R 2a , R 2b , R 2c , R 2d , R 2e , R 2f and R 2g are hydrogen atoms.

8. The compound according to claim 2 , a salt thereof or a hydrate of them, wherein Z 2 is a 1,2-ethylene group, a 1,2-vinylene group, a group represented by the formula —CO—NR 4a — wherein R 4a represents a hydrogen atom or a C 1 -C 6 alkyl group or a group represented by the formula —NR 4a —CO— wherein R 4a represents a hydrogen atom or a C 1 -C 6 alkyl group.

9. The compound according to claim 1 or 2 , a salt thereof or a hydrate of them, wherein the ring A is a benzene ring which may have one to three groups selected from the Substituent Group (a) described in claim 1 , a naphthalene ring which may have one to three groups selected from the Substituent Group (a) described in claim 1 , an indole ring which may have one to three groups selected from the Substituent Group (a) described in claim 1 , a benzofuran ring which may have one to three groups selected from the Substituent Group (a) described in claim 1 , a benzothiophene ring which may have one to three groups selected from the Substituent Group (a) described in claim 1 , a pyridine ring which may have one to three groups selected from the Substituent Group (a) described in claim 1 , a furan ring which may have one to three groups selected from the Substituent Group (a) described in claim 1 , or a thiophene ring which may have one to three groups selected from the Substituent Group (a) described in claim 1 .

10. The compound according to claim 1 or 2 , a salt thereof or a hydrate of them, wherein the ring A is a ring having one group selected from the Substituent Group (a) described in claim 1 .

11. The compound according to claim 1 , a salt thereof or a hydrate of them, wherein R 1a is a hydrogen atom.

12. The compound according to claim 1 , a salt thereof or a hydrate of them, wherein R 2a and R 2b are hydrogen atoms.

13. A c-Jun amino-terminal kinase (JNK) inhibitor, comprising the compound according to claim 1 , a salt thereof or a hydrate of them.

14. A c-Jun amino-terminal kinase 1 (JNK 1), c-Jun amino-terminal kinase 2 (JNK 2) and/or c-Jun amino-terminal kinase 3 (JNK 3) inhibitor, comprising the compound according to claim 1 , a salt thereof or a hydrate of them.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 29, 2007
From: EISAI CO., LTD.
To: EISAI R&D MANAGEMENT CO., LTD.
Reel/Frame 019500/0673 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 2, 2004
From: OHI, NORIHITO; SATO, NOBUAKI; KOHMURA, NAOHIRO
To: EISAI CO., LTD.
Reel/Frame 016750/0324 →
Priority Claims (1)
JP 2002-052890 · Feb 28, 2002 · national
Continuity (1)
Related Publication 20060111419A1 · May 25, 2006